FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Cyclophosphamide Tablets
Status: Discontinuation
»Therapeutic Categories: Oncology

Expand all

West-Ward Pharmaceuticals (New 11/01/2016)

Company Contact Information:
800-962-8364

Presentation Posting Date Related Information
Cyclophosphamide 25mg Tablets (NDC 0054-4129-25) 11/01/2016 Cyclophosphamide Capsules, 25 mg and 50 mg, were approved September 16, 2013 and are currently marketed under NDC numbers 0054-0382-25 (25 mg) and 0054-0383-25 (50 mg) in 100 count bottles.
Cyclophosphamide 25mg Tablets (NDC 0054-8089-25) 11/01/2016 Cyclophosphamide Capsules, 25 mg and 50 mg, were approved September 16, 2013 and are currently marketed under NDC numbers 0054-0382-25 (25 mg) and 0054-0383-25 (50 mg) in 100 count bottles.
Cyclophosphamide 50mg Tablets (NDC 0054-4130-25) 11/01/2016 Cyclophosphamide Capsules, 25 mg and 50 mg, were approved September 16, 2013 and are currently marketed under NDC numbers 0054-0382-25 (25 mg) and 0054-0383-25 (50 mg) in 100 count bottles.
Cyclophosphamide 50mg Tablets (NDC 0054-8130-25) 11/01/2016 Cyclophosphamide Capsules, 25 mg and 50 mg, were approved September 16, 2013 and are currently marketed under NDC numbers 0054-0382-25 (25 mg) and 0054-0383-25 (50 mg) in 100 count bottles.
Cyclophosphamide 50mg Tablets (NDC 0054-4130-29) 11/01/2016 Cyclophosphamide Capsules, 25 mg and 50 mg, were approved September 16, 2013 and are currently marketed under NDC numbers 0054-0382-25 (25 mg) and 0054-0383-25 (50 mg) in 100 count bottles.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English